Eculizumab: A Complementary addition to existing long-term therapies for myasthenia gravis

Muscle Nerve. 2019 Jul;60(1):7-9. doi: 10.1002/mus.26512. Epub 2019 May 16.

Authors

Christyn Edmundson¹, Amanda C Guidon²

Affiliations

¹ Division of Neuromuscular Medicine, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 820, Boston, Massachusetts, 02114, USA.

PMID: 31074870
DOI: 10.1002/mus.26512

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Humans
Myasthenia Gravis*

Substances

Antibodies, Monoclonal, Humanized
eculizumab